Abstract
Soluble guanylate cyclase (sGC) is highly activated in the presence of both YC-1 (1-benzyl-3-(5'-hydroxymethyl-2'-furyl)-indazole) and CO. In this report, the design, synthesis, and activity (i.e., sGC activation) of photolabile analogues of 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole (YC-1) are presented. Initial results with 6-azido-3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole led to the synthesis of a tritium-labeled analogue. When photoactivated, this analogue labeled the alpha-subunit of sGC.
MeSH terms
-
Drug Design
-
Enzyme Activation / drug effects
-
Enzyme Activators / chemistry
-
Enzyme Activators / pharmacology
-
Guanylate Cyclase / chemistry*
-
Guanylate Cyclase / metabolism
-
Indazoles / chemical synthesis*
-
Indazoles / pharmacology
-
Molecular Structure
-
Platelet Aggregation Inhibitors / chemistry
-
Platelet Aggregation Inhibitors / pharmacology
-
Solubility
-
Tritium / chemistry
Substances
-
Enzyme Activators
-
Indazoles
-
Platelet Aggregation Inhibitors
-
Tritium
-
3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole
-
Guanylate Cyclase